# Tandem Diabetes Care to acquire AMF Medical, developer of Sigi patch pump

Tandem Diabetes Care has entered into a definitive agreement to acquire AMF Medical SA, a Swiss developer of the Sigi Patch Pump. The deal includes a previous strategic investment of CHF 8.0 million, a cash payment of CHF 62.4 million at closing, and additional contingent earnout payments of up to CHF 129.6 million.

- Type: Acquisition
- Announced: 2022-12-13
- Where: Switzerland
- Status: announced
- Products: Sigi Patch Pump, insulin delivery devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Tandem Diabetes Care](https://endata.com/companies/29150.md) (acquirer)
- [AMF Medical](https://endata.com/companies/67294.md) (target)

## Sources

- [businesswire.com](https://www.businesswire.com/news/home/20221213005314/en/Tandem-Diabetes-Care-to-Acquire-Insulin-Patch-Pump-Developer-AMF-Medical), 2022-12-13: "This acquisition supports our commitment to drive growth through innovation, as AMF Medical has novel technology and a shared passion for creating easy-to-use solutions to improve the lives of people with diabetes."
- [nasdaq.com](https://www.nasdaq.com/press-release/tandem-diabetes-care-completes-acquisition-of-insulin-patch-pump-developer-amf), 2023-01-23: "AMF Medical's compelling technology aligns well with our strategic vision to include a patch pump in Tandem's portfolio of differentiated offerings."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.